iBio, Inc. (IBIO) stock
IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.75+0.04 (+5.86%)
Close on Nov 17, 2026Market cap $48.11MP/E –Yield –
iBio EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for iBio
iBio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?